Correlation
The correlation between PFE and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
PFE vs. ABBV
Compare and contrast key facts about Pfizer Inc. (PFE) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFE or ABBV.
Performance
PFE vs. ABBV - Performance Comparison
Loading data...
Key characteristics
PFE:
-0.46
ABBV:
0.83
PFE:
-0.52
ABBV:
1.21
PFE:
0.94
ABBV:
1.19
PFE:
-0.19
ABBV:
1.17
PFE:
-0.80
ABBV:
2.66
PFE:
14.30%
ABBV:
9.07%
PFE:
24.17%
ABBV:
28.28%
PFE:
-58.96%
ABBV:
-45.09%
PFE:
-54.50%
ABBV:
-13.31%
Fundamentals
PFE:
$133.32B
ABBV:
$327.88B
PFE:
$1.38
ABBV:
$2.34
PFE:
16.99
ABBV:
79.32
PFE:
0.59
ABBV:
0.40
PFE:
2.13
ABBV:
5.72
PFE:
1.48
ABBV:
230.90
PFE:
$62.46B
ABBV:
$57.37B
PFE:
$42.09B
ABBV:
$44.44B
PFE:
$16.71B
ABBV:
$16.36B
Returns By Period
In the year-to-date period, PFE achieves a -8.28% return, which is significantly lower than ABBV's 6.70% return. Over the past 10 years, PFE has underperformed ABBV with an annualized return of 0.81%, while ABBV has yielded a comparatively higher 15.54% annualized return.
PFE
-8.28%
-1.93%
-7.16%
-11.13%
-19.73%
-4.00%
0.81%
ABBV
6.70%
-4.61%
3.65%
23.40%
12.26%
19.77%
15.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PFE vs. ABBV — Risk-Adjusted Performance Rank
PFE
ABBV
PFE vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
PFE vs. ABBV - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 7.24%, more than ABBV's 3.43% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 7.24% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
ABBV AbbVie Inc. | 3.43% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
PFE vs. ABBV - Drawdown Comparison
The maximum PFE drawdown since its inception was -58.96%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for PFE and ABBV.
Loading data...
Volatility
PFE vs. ABBV - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 9.18%, while AbbVie Inc. (ABBV) has a volatility of 9.85%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
PFE vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. ABBV - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.